Sodium iodide i-123 - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sodium iodide i-123 and what is the scope of freedom to operate?
Sodium iodide i-123
is the generic ingredient in one branded drug marketed by Cardinal Health 418, Curium, and Ge Healthcare, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for sodium iodide i-123. Two suppliers are listed for this compound.
Summary for sodium iodide i-123
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 3 |
NDAs: | 4 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 18 |
Patent Applications: | 10 |
Formulation / Manufacturing: | see details |
DailyMed Link: | sodium iodide i-123 at DailyMed |
Recent Clinical Trials for sodium iodide i-123
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Health Network, Toronto | Phase 4 |
Stryker Endoscopy | Phase 4 |
Osaka University | Phase 1 |
US Patents and Regulatory Information for sodium iodide i-123
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Curium | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 071910-001 | Feb 28, 1989 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cardinal Health 418 | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 018671-002 | May 27, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cardinal Health 418 | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 018671-003 | May 27, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |